SNBL-Gemseki - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeSNBL-Gemseki
SNBL-Gemseki logo

SNBL-Gemseki

0 followers

About SNBL-Gemseki

Gemseki Inc., headquartered in Tokyo and a spin-off from Japan's largest CRO SHIN NIPPON BIOMEDICAL LABORATORIES, supports drug and medical technology development by accelerating pharmaceutical licensing. They operate a global Drug Candidate Marketplace featuring hundreds of drug candidates and platform technologies for licensing, with team members across the U.S., Spain, and Taiwan providing multilingual support.

Recent News

No recent news for this company.

Recent Deals

Key Facts

HQ Location

Japan

Founded

2017

Employees

1 - 10

Status

Private

Website

https://gemseki.com